ClinicalTrials.gg
RecruitingNCT05906225Updated Nov 18, 2026

Anesthesia and EEG Discontinuity in Infants

An interventional study of EEG guided anesthesia and Conventional anesthesia in Anesthesia, General, Electroencephalography and Infant, sponsored by Seoul National University Hospital. Recruiting at 1 site in South Korea. Open to participants aged Up to 12 Months. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2023; still recruiting 3 years 5 months later.
Updated Nov 18, 2026Now RecruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
Up to 12 Months
Sex
All
01

Study summary

This study is a randomized controlled trial to evaluate whether EEG-guided calibration of inhalation agents can reduce occurrence of EEG discontinuity in infants during general anesthesia.

Read the detailed description

This is a study for comparison of incidence of EEG discontinuity during general anesthesia using sevoflurane. EEG guidance group will receive calibration of fraction of inhalational sevoflurane according to components of slow wave and delta wave of raw EEG. Control group will receive conventional management of anesthesia according to vital signs.

02

Conditions studied

  • Anesthesia, General
  • Electroencephalography
  • Infant
  • Anesthesia, Inhalation

Keywords

  • Electroencephalography
  • Infant
  • General anesthesia
  • Burst suppression
  • Sevoflurane
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,903 studies on the registry; 276 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 12 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants who were born as full-term (>37 weeks postconception) and are equal to or less than 12 month old who were scheduled to undergo surgery under general anesthesia using inhalation agents.
  • Belongs to Physical Status 1 or 2

Exclusion criteria

Exclusion Criteria:

  • Infants who were born less than 37 weeks postconception or has history of mechanical ventilation immediately after birth
  • Presence of any genetic disease, chromosomal anomaly or congenital anomaly that can affect brain development
  • Presence of any disease or disability in central nervous system
  • History of trauma at head or surgery on brain
  • History of to any anesthetic agents
  • Status of sedation or endotracheal intubation before induction of anesthesia
  • Inability to attach probes for EEG monitoring
  • Expectation of operation time as less than 5 minutes
  • Other conditions that researchers regard as inappropriate for enrollment
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Experimental
    Electroencephalogram

    Adjustment of concentration of sevoflurane according to EEG

    Procedure: EEG guided anesthesia

  • Active comparator
    Conventional

    Adjustment of concentration of sevoflurane according to vital signs

    Procedure: Conventional anesthesia

Interventions

  • ProcedureEEG guided anesthesia

    Monitoring of electroencephalogram via Sedline probe by MASIMO corporation. Adjust concentration of inhalational sevoflurane during anesthesia, according to component of slow\&delta wave and alpha wave, so that slow/delta oscillation (with or without alpha oscillation) is maintained.

  • ProcedureConventional anesthesia

    Adjust concentration of inhalational sevoflurane during anesthesia, according to vital signs, so that mean blood pressure and heart rate are maintained between 80% and 120% of baseline values measured at ward before anesthesia.

06

What researchers measure

Primary outcomes

  1. EEG discontinuity

    Incidence of EEG discontinuity (EEG amplitudes \< 25uV for more than 2 seconds)

    Time frame: From start of anesthesia to end of anesthesia, Less than 24 hours

Secondary outcomes

  1. Total duration of EEG discontinuity

    Total sum of duration of EEG discontinuity

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  2. Significant isoelectric EEG

    Incidence of significant isoelectric EEG (EEG amplitudes \< 10uV for more than 2 seconds)

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  3. EtSev

    Mean end-tidal sevoflurane concentration during anesthesia

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  4. SEF

    Mean spectral edge frequency value during anesthesia

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  5. PSi

    Mean patient state index value during anesthesia

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  6. Mean blood pressure

    Mean blood pressure values during anesthesia measured every 2.5 minutes

    Time frame: From start of anesthesia to end of study, Less than 24 hours

  7. Heart rate

    Heart rate values during anesthesia measured every 2.5 minutes

    Time frame: From start of anesthesia to end of study, Less than 24 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Cornelissen L, Kim SE, Purdon PL, Brown EN, Berde CB. Age-dependent electroencephalogram (EEG) patterns during sevoflurane general anesthesia in infants. Elife. 2015 Jun 23;4:e06513. doi: 10.7554/eLife.06513. PubMed 26102526 ↗
  • Cornelissen L, Kim SE, Lee JM, Brown EN, Purdon PL, Berde CB. Electroencephalographic markers of brain development during sevoflurane anaesthesia in children up to 3 years old. Br J Anaesth. 2018 Jun;120(6):1274-1286. doi: 10.1016/j.bja.2018.01.037. Epub 2018 Apr 5. PubMed 29793594 ↗
  • Tokuwaka J, Satsumae T, Mizutani T, Yamada K, Inomata S, Tanaka M. The relationship between age and minimum alveolar concentration of sevoflurane for maintaining bispectral index below 50 in children. Anaesthesia. 2015 Mar;70(3):318-22. doi: 10.1111/anae.12890. Epub 2014 Oct 1. PubMed 25271891 ↗
  • Purdon PL, Sampson A, Pavone KJ, Brown EN. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology. 2015 Oct;123(4):937-60. doi: 10.1097/ALN.0000000000000841. PubMed 26275092 ↗
  • Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010 Dec 30;363(27):2638-50. doi: 10.1056/NEJMra0808281. No abstract available. PubMed 21190458 ↗
  • Bong CL, Long MHY. Sevoflurane requirements during electroencephalogram (EEG)-guided vs standard anesthesia care in children: A randomized controlled trial. J Clin Anesth. 2023 Jun;86:111071. doi: 10.1016/j.jclinane.2023.111071. Epub 2023 Feb 13. No abstract available. PubMed 36774668 ↗
  • Pawar N, Barreto Chang OL. Burst Suppression During General Anesthesia and Postoperative Outcomes: Mini Review. Front Syst Neurosci. 2022 Jan 7;15:767489. doi: 10.3389/fnsys.2021.767489. eCollection 2021. PubMed 35069132 ↗
  • Yuan I, Landis WP, Topjian AA, Abend NS, Lang SS, Huh JW, Kirschen MP, Mensinger JL, Zhang B, Kurth CD. Prevalence of Isoelectric Electroencephalography Events in Infants and Young Children Undergoing General Anesthesia. Anesth Analg. 2020 Feb;130(2):462-471. doi: 10.1213/ANE.0000000000004221. PubMed 31107263 ↗
  • Gao Z, Zhang J, Wang X, Yao M, Sun L, Ren Y, Qiu D. A retrospective study of electroencephalography burst suppression in children undergoing general anesthesia. Pediatr Investig. 2021 Aug 16;5(4):271-276. doi: 10.1002/ped4.12287. eCollection 2021 Dec. PubMed 34938968 ↗
  • Cornelissen L, Bergin AM, Lobo K, Donado C, Soul JS, Berde CB. Electroencephalographic discontinuity during sevoflurane anesthesia in infants and children. Paediatr Anaesth. 2017 Mar;27(3):251-262. doi: 10.1111/pan.13061. Epub 2017 Feb 8. PubMed 28177176 ↗
  • Yuan I, Xu T, Skowno J, Zhang B, Davidson A, von Ungern-Sternberg BS, Sommerfield D, Zhang J, Song X, Zhang M, Zhao P, Liu H, Jiang Y, Zuo Y, de Graaff JC, Vutskits L, Olbrecht VA, Szmuk P, Kurth CD; BRAIN Collaborative Investigators. Isoelectric Electroencephalography in Infants and Toddlers during Anesthesia for Surgery: An International Observational Study. Anesthesiology. 2022 Aug 1;137(2):187-200. doi: 10.1097/ALN.0000000000004262. PubMed 35503999 ↗
  • Katoh T, Kobayashi S, Suzuki A, Kato S, Iwamoto T, Bito H, Sato S. Fentanyl augments block of sympathetic responses to skin incision during sevoflurane anaesthesia in children. Br J Anaesth. 2000 Jan;84(1):63-6. doi: 10.1093/oxfordjournals.bja.a013384. PubMed 10740549 ↗
  • Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008 Mar 13;358(11):1097-108. doi: 10.1056/NEJMoa0707361. PubMed 18337600 ↗
  • Lerman J, Sikich N, Kleinman S, Yentis S. The pharmacology of sevoflurane in infants and children. Anesthesiology. 1994 Apr;80(4):814-24. doi: 10.1097/00000542-199404000-00014. PubMed 8024136 ↗
  • Chao JY, Gutierrez R, Legatt AD, Yozawitz EG, Lo Y, Adams DC, Delphin ES, Shinnar S, Purdon PL. Decreased Electroencephalographic Alpha Power During Anesthesia Induction Is Associated With EEG Discontinuity in Human Infants. Anesth Analg. 2022 Dec 1;135(6):1207-1216. doi: 10.1213/ANE.0000000000005864. Epub 2022 Nov 16. PubMed 35041633 ↗
  • Lee HC, Jung CW. Vital Recorder-a free research tool for automatic recording of high-resolution time-synchronised physiological data from multiple anaesthesia devices. Sci Rep. 2018 Jan 24;8(1):1527. doi: 10.1038/s41598-018-20062-4. PubMed 29367620 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2023 (actual). Primary completion is estimated for Mar 2027, 45 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Mar 2025 → Mar 2027 and completion May 2025 → May 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2023
First posted
Jun 15, 2023
StartActual
Jun 20, 2023
Primary completionEst.
Mar 30, 2027was Mar 2025
CompletionEst.
May 30, 2027was May 2025
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Primary completion
Mar 30, 2025→Mar 30, 2027
Nov 18, 2026
Study completion
May 30, 2025→May 30, 2027
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Primary completion Mar 30, 2025→Mar 30, 2027
    Study completion May 30, 2025→May 30, 2027
    + 2 other changes: verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05906225
Responsible party
Ji-Hyun Lee (Clinical Associate Professor, Seoul National University Hospital) — Principal investigator
First posted
Jun 15, 2023
Start date
Jun 20, 2023
Primary completion
Mar 30, 2027 (estimated)
Completion
May 30, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Sang-Hwan Ji, M.D., Ph.D.
Contact
taepoongshin@gmail.com
+82-2-2072-3661
Ji-Hyun Lee, M.D., Ph.D.
principal investigator · Seoul National University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion